Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-379276
Filing Date
2017-12-27
Accepted
2017-12-27 09:32:43
Documents
2
Period of Report
2017-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d706479d6k.htm 6-K 12068
2 GRAPHIC g706479g81t93.jpg GRAPHIC 35480
  Complete submission text file 0001193125-17-379276.txt   62029
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 171275315
SIC: 2834 Pharmaceutical Preparations